Illumina (ILMN) Competitors $97.78 +1.10 (+1.14%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$98.44 +0.66 (+0.67%) As of 10/8/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, BIO, CRL, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Bio-Rad Laboratories Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk. Does the media prefer A or ILMN? In the previous week, Agilent Technologies had 15 more articles in the media than Illumina. MarketBeat recorded 32 mentions for Agilent Technologies and 17 mentions for Illumina. Agilent Technologies' average media sentiment score of 0.97 beat Illumina's score of 0.88 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 14 Very Positive mention(s) 7 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 10 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, A or ILMN? Agilent Technologies has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Do institutionals and insiders have more ownership in A or ILMN? 89.4% of Illumina shares are owned by institutional investors. 2.6% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate A or ILMN? Agilent Technologies currently has a consensus price target of $147.92, suggesting a potential upside of 5.05%. Illumina has a consensus price target of $123.56, suggesting a potential upside of 26.36%. Given Illumina's higher possible upside, analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.57Illumina 3 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.15 Which has stronger earnings and valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B6.13$1.29B$4.2633.05Illumina$4.37B3.44-$1.22B$7.9012.38 Is A or ILMN more profitable? Illumina has a net margin of 29.36% compared to Agilent Technologies' net margin of 17.97%. Illumina's return on equity of 28.93% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies17.97% 25.51% 12.94% Illumina 29.36%28.93%10.74% SummaryAgilent Technologies beats Illumina on 9 of the 16 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.86B$3.35B$6.10B$10.55BDividend YieldN/A2.28%5.69%4.75%P/E Ratio12.3821.5785.4727.60Price / Sales3.44426.57601.78232.87Price / Cash20.6147.1237.9261.55Price / Book6.5410.1413.136.76Net Income-$1.22B-$52.31M$3.30B$275.88M7 Day Performance-1.53%5.14%4.29%2.81%1 Month Performance-0.45%14.68%9.45%9.24%1 Year Performance-30.16%30.98%86.64%35.42% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.771 of 5 stars$97.78+1.1%$123.56+26.4%-30.0%$14.86B$4.37B12.389,030Analyst ForecastAAgilent Technologies4.001 of 5 stars$123.70+0.3%$140.08+13.2%-2.6%$35.07B$6.51B29.0417,900Trending NewsAnalyst ForecastMTDMettler-Toledo International3.892 of 5 stars$1,191.70-1.1%$1,325.56+11.2%-8.5%$24.55B$3.87B30.1817,300Analyst ForecastWATWaters4.5585 of 5 stars$289.19-0.9%$378.73+31.0%-8.6%$17.21B$2.96B26.087,600Trending NewsAnalyst ForecastTECHBio-Techne4.7806 of 5 stars$52.23+0.7%$70.42+34.8%-17.9%$8.13B$1.22B113.553,100Analyst UpgradeBIOBio-Rad Laboratories4.3862 of 5 stars$269.95-0.5%$333.50+23.5%-10.8%$7.30B$2.57B23.017,700Positive NewsCRLCharles River Laboratories International4.2507 of 5 stars$146.88-1.1%$177.07+20.6%-7.1%$7.23B$4.05B-110.4320,100Analyst UpgradeBRKRBruker4.944 of 5 stars$30.88-0.5%$51.30+66.1%-46.7%$4.69B$3.37B59.3911,396Analyst ForecastPACBPacific Biosciences of California1.9964 of 5 stars$1.25+3.3%$1.90+52.0%-10.7%$375.46M$154.01M-0.55730News CoverageAnalyst ForecastHBIOHarvard Bioscience4.4276 of 5 stars$0.44-0.9%$2.00+354.8%-81.5%$19.58M$94.14M-0.34490Positive NewsAnalyst ForecastTMOThermo Fisher Scientific4.8911 of 5 stars$461.95-0.5%$588.35+27.4%-9.9%$174.44B$42.88B26.72125,000Trending NewsAnalyst Forecast Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
